153 related articles for article (PubMed ID: 30050595)
21. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
22. Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes.
Lim T; Kim SJ; Kim K; Lee JI; Lim DH; Lee DJ; Baek KK; Lee HY; Han B; Uhm JE; Ko YH; Kim WS
Ann Hematol; 2011 Dec; 90(12):1391-8. PubMed ID: 21479535
[TBL] [Abstract][Full Text] [Related]
23. Incidence, clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO.
Krogh-Jensen M; d'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ann Oncol; 1994 Apr; 5(4):349-54. PubMed ID: 8075032
[TBL] [Abstract][Full Text] [Related]
24. MYC, BCL2, and BCL6 rearrangements in primary central nervous system lymphoma of large B cell type.
Nosrati A; Monabati A; Sadeghipour A; Radmanesh F; Safaei A; Movahedinia S
Ann Hematol; 2019 Jan; 98(1):169-173. PubMed ID: 30306208
[TBL] [Abstract][Full Text] [Related]
25. Primary central nervous system lymphomas: a 30-year experience at a single institution.
Nuckols JD; Liu K; Burchette JL; McLendon RE; Traweek ST
Mod Pathol; 1999 Dec; 12(12):1167-73. PubMed ID: 10619271
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological features, survival and prognostic factors of primary central nervous system lymphomas: trends in incidence of primary central nervous system lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the Danish Lymphoma Registry, LYFO, and the Danish Cancer Registry.
Krogh-Jensen M; D'Amore F; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Leuk Lymphoma; 1995 Oct; 19(3-4):223-33. PubMed ID: 8535213
[TBL] [Abstract][Full Text] [Related]
27. Activated B-cell immunophenotype might be associated with poor prognosis of primary central nervous system lymphomas.
Bhagavathi S; Sharathkumar A; Hunter S; Sung L; Kanhere R; Venturina MD; Wilson JD
Clin Neuropathol; 2008; 27(1):13-20. PubMed ID: 18257470
[TBL] [Abstract][Full Text] [Related]
28. Primary central nervous system lymphoma in immunocompetent individuals: a single center experience.
Aki H; Uzunaslan D; Saygin C; Batur S; Tuzuner N; Kafadar A; Ongoren S; Oz B
Int J Clin Exp Pathol; 2013; 6(6):1068-75. PubMed ID: 23696924
[TBL] [Abstract][Full Text] [Related]
29. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
30. MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system.
Kim S; Nam SJ; Kwon D; Kim H; Lee E; Kim TM; Heo DS; Park SH; Kim CW; Jeon YK
BMC Cancer; 2016 Jun; 16():363. PubMed ID: 27286976
[TBL] [Abstract][Full Text] [Related]
31. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
Mao C; Chen F; Li Y; Jiang X; Liu S; Guo H; Huang L; Wei X; Liang Z; Li W; Tang K
World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis, prognosis and treatment of primary central nervous system lymphoma in the elderly population (Review).
Liu Y; Yao Q; Zhang F
Int J Oncol; 2021 Mar; 58(3):371-387. PubMed ID: 33650642
[TBL] [Abstract][Full Text] [Related]
33. CNS lymphoma, the Irish experience: A retrospective review of neuropathologically confirmed cases over 10 years.
O'Connell K; Looby S; Gou P; Flavin R; Farrell M; Cryan JB; Beausang A; Brett FM
Clin Neuropathol; 2020; 39(5):212-220. PubMed ID: 32301694
[TBL] [Abstract][Full Text] [Related]
34. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
Le M; Garcilazo Y; Ibáñez-Juliá MJ; Younan N; Royer-Perron L; Benazra M; Mokhtari K; Houillier C; Hoang-Xuan K; Alentorn A
Oncologist; 2019 Sep; 24(9):e898-e904. PubMed ID: 30867243
[TBL] [Abstract][Full Text] [Related]
35. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
[TBL] [Abstract][Full Text] [Related]
36. Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma.
Zhao D; Qian L; Shen J; Liu X; Mei K; Cen J; Wang Y; Li C; Ma Y
J Cell Mol Med; 2014 Jun; 18(6):1081-6. PubMed ID: 24628986
[TBL] [Abstract][Full Text] [Related]
37. Clinical characteristics and outcomes of primary adrenal diffuse large B cell lymphoma in a large contemporary cohort: a SEER-based analysis.
Li S; Wang Z; Wu Z; Zhuang H; Xu Y
Ann Hematol; 2019 Sep; 98(9):2111-2119. PubMed ID: 31227873
[TBL] [Abstract][Full Text] [Related]
38. Survival among patients with primary central nervous system lymphoma, 1973-2004.
Norden AD; Drappatz J; Wen PY; Claus EB
J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
[TBL] [Abstract][Full Text] [Related]
39. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system lymphoma.
Stern JI; Raizer JJ
Expert Rev Neurother; 2005 Nov; 5(6 Suppl):S63-70. PubMed ID: 16274272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]